The 20 Best Esophageal Cancer Doctors Near Me in Ann Arbor, MI

Joel Rubenstein, M.D., M.Sc. is Director of the Barrett's Esophagus Program and Professor in the Division of Gastroenterology at the University of Michigan. He is also a Research Scientist at the Veterans Affairs Center of Excellence for Clinical Management Research.Dr. Rubenstein earned a Bachelors of Science from the University of Michigan, majoring in biophysics. He then earned his medical degree from Washington University in St. Louis. After completing his residency training in internal medicine at the University of Chicago, Dr. Rubenstein returned to the University of Michigan, where he completed fellowship training in gastroenterology, earned a Masters of Science in Clinical Research Design and Statistical Analysis, and then joined the faculty of the Division of Gastroenterology in 2004.Dr. Rubenstein is a recognized expert in the diagnosis and management of Barrett's esophagus, a precancerous lesion associated with esophageal cancer. His research aims to develop efficient management strategies for identifying Barrett's esophagus and preventing death from esophageal cancer. Dr. Rubenstein's research has been supported by the National Institutes of Health, the Department of Veterans Affairs, Department of Defense, the Damon Runyon Cancer Research Foundation, and other sources. In addition to Barrett's esophagus, Dr. Rubenstein has clinical expertise in other esophageal disoders, including achalasia and eosinophilic esophagitis.Dr. Rubenstein is the former Chair of the Clinical Practice Section of the American Gastroenterology Association, and current Associated Editor of the American Journal of Gastroenterology. Dr. Rubenstein is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Gastroesophageal Reflux Disease (GERD), Esophageal Cancer, Endoscopy, and Colonoscopy. Dr. Rubenstein is board certified in Gastroenterology.

Rishindra M. Reddy, M.D., is the José José Alvarez Research Professor in Thoracic Surgery. He was born and raised in Michigan. He earned his undergraduate and medical degrees at Northwestern University, and completed his general surgery residency at Washington University-Barnes Jewish Hospital in St. Louis, Missouri. His spent two years during his residency, as a Clinical Research Fellow at the National Cancer Institute in Bethesda, Maryland. He completed his Thoracic Surgery residency at the University of Washington and was a visiting fellow at Memorial Sloan Kettering Cancer Center in New York. His academic interests include improving outcomes for patients with thoracic cancers, molecular targeting for thoracic cancers, resident and medical student education.Clinical Specialization: Dr. Reddy's clinical interests include all aspects of general thoracic surgery including thoracic oncology, minimally invasive techniques and robotics surgery, esophageal diseases, pectus repairs and therapy for end stage lung disease including transplantation and lung volume surgery. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Hiatal Hernia, Esophageal Cancer, Endoscopy, and Lung Transplant. Dr. Reddy is board certified in Surgery and Thoracic & Cardiac Surgery.

Andrew C. Chang, M.D., is the Cameron Haight Collegiate Professor of Thoracic Surgery at the University of Michigan. After completing his undergraduate education at the Massachusetts Institute of Technology and medical education at The Johns Hopkins University he pursued general surgical residency at Vanderbilt University. During this time he also obtained an individual National Research Service Award from the National Institutes of Health to study cardiothoracic transplantation with Richard N. Pierson, III, M.D. He then continued as a thoracic surgical resident and subsequently thoracic surgical fellow at the University of Michigan, completing these in 2003, before joining the faculty. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Achalasia, Hiatal Hernia, Hernia, Endoscopy, and Lung Transplant. Dr. Chang is board certified in Surgery and Thoracic & Cardiac Surgery.

Mark Orringer is a General Surgeon and a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Orringer is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Esophageal Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Barrett Esophagus, and Endoscopy. Dr. Orringer is board certified in Surgery and Thoracic & Cardiac Surgery.

Dr. Lagisetty serves as an Assistant Professor of Surgery in the Section of Thoracic Surgery at the University of Michigan Health System.He is a graduate from the University of Alabama at Birmingham with a degree in Philosophy in 2003 and medical degree in 2007. His General Surgical residency was completed at Beth Israel Deaconess Medical Center/Harvard Medical School. Dr. Lagisetty spent two years as a Clinical Research Fellow at the National Institutes of Health studying tumor immunology and genetic engineering/therapy. After residency he completed a two year Thoracic Surgery Fellowship at the University of Michigan.Clinical Specialization: Dr. Lagisetty specializes in all areas of general thoracic surgery, benign and malignant esophageal disorders, benign and malignant lung resections, minimally invasive including robotic techniques, lung transplantation. Dr. Lagisetty is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Congenital Diaphragmatic Hernia, Hernia, Endoscopy, and Lung Transplant. Dr. Lagisetty is board certified in Surgery and Thoracic & Cardiac Surgery.

David Odell is a General Surgeon and a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Odell is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Nodules, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy.

Chigozirim Ekeke is a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Ekeke is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Pleural Effusion, Metastatic Pleural Tumor, Hiatal Hernia, Endoscopy, and Advanced Bronchoscopy.

William R. Lynch, M.D., is the Associate Professor of Surgery for the Section of Thoracic Surgery in the clinical track in the Department of Surgery, Section of Thoracic Surgery. He will also provide services at the Ann Arbor Veterans Administration Hospital and have a dry appointment in the College of Engineering, Department of Biomedical Engineering.Principal responsibilities include clinical care, teaching, clinical research and program development, particularly implementation of ex vivo lung perfusion and other means of advanced donor organ management into our pulmonary transplantation program. Dr. Lynch will be mentored with Dr. Robert Bartlett. Primary research responsibilities are conducting independent scholarly investigations in the ECMO and critical care. Dr. Lynch has served as Chairman-Elect for the ELSO Steering Committee since 2010, and has had eight publications in peer-reviewed journals.Dr. Lynch received his Medical Degree (1994) from the University of Michigan, and completed his General Surgery residency (2000) at Milton S. Hershey Medical Center, Hershey, Pennsylvania. He completed his Thoracic Surgery residency at the University of Michigan in 2003. He was a Fellow in Extracorporeal Life Support (1998) and in Surgical Critical Care (1999) at the University of Michigan and more recently had a Fellowship in Lung Transplantation (2011) with the Toronto Lung Transplant Group, Toronto, Ontario. Clinical Specialization: Dr. Lynch specializes in all aspects of general thoracic surgery including pulmonary transplantation and thoracic oncology. Dr. Lynch is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Pleurisy, Pleuropulmonary Blastoma, Lung Transplant, and Endoscopy. Dr. Lynch is board certified in Surgery, Thoracic & Cardiac Surgery, and Surgical Critical Care.

Dr. Kwon joined the Division of Gastroenterology in 2005 and is currently a Clinical Professor. He received his bachelor's degree from Amherst College and his medical degree from UCLA Medical School. He completed his internal medicine residency at Cedars-Sinai Medical Center and his gastroenterology fellowship at Brigham and Women's Hospital (BWH). He also completed his advanced endoscopy fellowship at the combined BWH and Massachusetts General Hospital program. He earned his Master of Science in Clinical Research Design and Statistical Analysis at the University of Michigan. Dr. Kwon is currently the Director of Advanced Endoscopy, Program Director for the Advanced Endoscopy fellowship, and Co-director of the Comprehensive Pancreas Program. He also serves as the Medical Director of the Michigan Chapter of the National Pancreas Foundation. He is a principal investigator in several independently funded research studies and has been an author on over 100 publications, including multiple research studies, national guidelines, and book chapters. He is a sought-after speaker, having served as invited faculty at multiple regional, national and international courses. Dr. Kwon is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Bile Duct Obstruction, Pancreatic Cancer, Endoscopy, and Lithotripsy. Dr. Kwon is board certified in Gastroenterology.

Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is board certified in Medical Oncology.

Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.

Dr. Saini is a general gastroenterologist and health services researcher. His clinical practice is based primarily at the VA Ann Arbor Healthcare System. His research focuses on developing and testing interventions to reduce the use of low-value care as well as strategies to improve access to resource-limited specialty care services (such as gastrointestinal endoscopy). He uses a variety of methodological approaches in his work, including simulation modeling, mixed-methods, and implementation science. He also has a strong interest in mentoring and career development and currently serves as primary mentor to two NIH K awardees and one VA Career Development Awardee. He is the Director of the VA Ann Arbor HSR Center for Clinical Management Research (CCMR), one of the nation’s leading VA Centers of Innovation (COINs). Dr. Saini is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Gastrointestinal Bleeding, Colorectal Cancer, Viral Gastroenteritis, Colonoscopy, and Endoscopy.

Dr. Lawrence structured his career to prepare to be a physician scientist by obtaining both an MD and PhD. He initially pursued internal medicine and medical oncology, but ultimately settled on radiation oncology. He is board certified in all 3 areas. He has had an active clinical practice in radiation oncology for 30 years specializing in the treatment of patients with gastrointestinal malignancies and CNS tumors.Dr. Lawrence has focused his research career in two main areas. First, in collaboration with basic scientists he developed a laboratory program in chemotherapeutic radiation sensitizers and, more recently, has studied how to integrate molecularly targeted therapies. He collaborates with basic science faculty interested in translational research to investigate new combinations that can form the basis for rational clinical trials. The second area of focus involves the use of highly conformal radiation therapy in the treatment of brain and gastrointestinal cancers. In particular, he is focusing, in collaboration with medical physicists, radiologists, imaging scientists, and biologists, on the concept of adapting treatment to the individual patient response, assessed both by state-of-the-art imaging and plasma biomarkers.Dr. Lawrence is the author of over 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 20 years. Dr. Lawrence is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Lawrence is board certified in Radiation Oncology, Medical Oncology, and Internal Medicine.

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Cho is board certified in Surgery.

Leslie Fecher, MD, joined the faculty on from Indiana University School of Medicine's Simon Cancer Center. Dr. Fecher completed her BA in Biochemistry at Rice University in Houston, and earned her MD from Indiana University School of Medicine. She completed her residency at University of Texas Southwestern in Dallas, followed by an Oncology Fellowship at Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center in Baltimore. Dr. Fecher was an assistant professor of medicine at the Abramson Cancer Center in Philadelphia for four years where she held a secondary appointment in Dermatology. She subsequently joined the faculty at Indiana University in 2011. Dr. Fecher is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Tissue Biopsy.

David Elliott is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Elliott is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Prostate Cancer. Dr. Elliott is board certified in Radiation Oncology.

Dr. Hari Nathan is a board-certified complex general surgical oncologist and Associate Professor of Surgery with Tenure. Dr. Nathan completed both his undergraduate and medical education with honors at The Johns Hopkins University. He also completed advanced training in health services research and was awarded a PhD from The Johns Hopkins Bloomberg School of Public Health. Dr. Nathan completed his clinical residency training in general surgery at The Johns Hopkins Hospital. He subsequently completed a clinical fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center, where he also served as the Chief Administrative Fellow in Surgery. He joined the faculty of the University of Michigan in 2014. Clinical Specialization: Dr. Nathan's clinical focus includes the multi-disciplinary treatment of tumors of the pancreas, liver, bile duct, and stomach. He has particular interests in the treatment of liver metastases from colorectal cancer and directs Michigan Medicine’s Hepatic Artery Infusion Pump (HAIP) Program. He also serves as the Surgical Director of the Multidisciplinary Pancreatic Cancer Clinic, coordinating the efforts of a multidisciplinary team at the busiest pancreatic cancer program in Michigan. Dr. Nathan is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Nathan is board certified in Surgery and Complex General Surgical Oncology.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Stewart Wang is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Stevens-Johnson Syndrome, Erythema Multiforme, Obesity, Tenotomy, and Pancreaticoduodenectomy. Dr. Wang is currently accepting new patients.